SAJDVD: VOLUME 19, ISSUE
1, July
2022
This journal is now available to be viewed via our eJournal publication viewer.
- From the Editor’s Desk
Authors: Mahomed, FA
From: South African Journal of Diabetes and Vascular Disease, Vol 19, Issue 1, July 2022
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
- Prevalence of the metabolic syndrome among Batswana adults in Gaborone and surrounding villages
Authors: Dawn Tladi, Lucky Mokgatlhe, Theo Nell, Ronel Michell, Sheila Shaibu, Comfort Mokgothu, Tebogo Gabonthone, Omphile Hubona, Kotsedi Monyeki
From: South African Journal of Diabetes and Vascular Disease, Vol 19, Issue 1, July 2022
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
Background: Non-communicable diseases (NCDs), including hypertension, diabetes and obesity, are on the increase in Botswana and yet the prevalence of the metabolic syndrome (MetS) among the apparently healthy Batswana is unknown.
Objective: The study aimed to describe the prevalence of the MetS among apparently healthy Batswana adults. Methods: A cross-sectional, descriptive study was used to collect demographic and anthropometric (weight, height, waist and hip circumferences) data, and blood pressure (BP), blood glucose, triglyceride, high-density lipoprotein cholesterol (HDL-C) and total cholesterol measurements from 800 participants.
Results: The prevalence of the MetS was 32.7%, with women mostly afflicted (44.5%). Low HDL-C levels (50%) in women and hypertension (HTN) (50.3%) in men were the most prevalent individual components. Older participants showed a high prevalence (55–65 years; 57.2%), followed by a fairly high prevalence among the younger age group (25–34 years; men 39.0% vs women 26.6%).
Conclusion: There was an overall high prevalence of the MetS among the Batswana adults in the study, with women in general and the younger population at high risk for NCDs. Further research is necessary to establish additional risk factors, guidelines, strategic plans and appropriate public health interventions.
- Pre-morbid cardiometabolic risks among South Africans living in informal settlements
Authors: Kebogile Mokwena, Perpetua ModjadjI
From: South African Journal of Diabetes and Vascular Disease, Vol 19, Issue 1, July 2022
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
Aim: Numerous studies have been conducted on cardiometabolic risk factors in South Africa. However, not much has been done in informal settlement populations faced with their own set of health risks. This study screened for pre-morbid cardiometabolic risks and associated factors among adults living in informal settlements in South Africa.
Methods: A cross-sectional study used the WHO STEPwise questionnaire to collect data on demography, anthropometry, blood pressure, and glucose and cholesterol levels (n = 329). Cardiometabolic risks were based on the criteria considered by the International Diabetes Federation and the National Cholesterol Education Program Adult Treatment Panel III. Data were analysed using STATA 14.
Results: The median age was 35 (25–42) years. Cardiometabolic risk factors in the study subjects were hypertension (66%), overweight/obesity (45%), abdominal obesity (46%), and elevated cholesterol (15%) and glucose levels (7%). The metabolic syndrome was found in 17% of the subjects, with a high prevalence observed among participants aged 35–59 years (28%) and ≥ 60 years (40%). The metabolic syndrome was significantly associated with gender [males, adjusted odds ratio (AOR) = 0.4, 95% CI: 0.20–0.90] and age, 35–59 years (AOR = 5.07, 95% CI: 2.24– 11.23) and ≥ 60 years (AOR = 6.57, 95% CI; 1.57–27.54).
Conclusion: Prevalent cardiometabolic risk factors in informal settlements indicate the need for routine screening for all the components of the metabolic syndrome at the primary healthcare level.
- American Diabetes Association updates its Standards of Medical Care for 2022
From: South African Journal of Diabetes and Vascular Disease, Vol 19, Issue 1, July 2022
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
Introduction: The American Diabetes Association (ADA) updated its Standards of Medical Care supplement in December, to provide clinicians, researchers, policy makers and other interested individuals with the components of diabetes care, general treatment goals and tools to evaluate the quality of care.
- New research holds big promise for a type 1 diabetes cure
From: South African Journal of Diabetes and Vascular Disease, Vol 19, Issue 1, July 2022
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
Introduction: An experimental implant containing stem cells designed to mature into insulin-secreting cells passed its first human trails. The studies reported the implant (designed to replace the missing insulin cells) to be mildly effective, offering promising signs of a ‘functional cure’ for diabetics with type 1 diabetes.
- Verapamil benefits for type 1 diabetes evident two years later
From: South African Journal of Diabetes and Vascular Disease, Vol 19, Issue 1, July 2022
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
Introduction: Using the drug verapamil to treat type 1 diabetes continues to show benefits lasting at least two years, US researchers have reported. Patients taking the oral blood pressure medication not only required less daily insulin two years after first diagnosis of the disease, but also showed evidence of surprising immunomodulatory benefits.
- AHA names 2021’s top advances in heart disease and stroke research
From: South African Journal of Diabetes and Vascular Disease, Vol 19, Issue 1, July 2022
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
Introduction: A major funder of heart- and strokerelated research, the American Heart Association (AHA) compiles an annual recap of noteworthy scientific studies. Here is an overview of 2021’s pivotal developments.
LATEST EDITORS' CHOICE
Interesting
features, including:
- Cardiometabolic risk factors in male long-distance bus drivers
- Endothelial dysfunction in patients with hyperlipidaemia
- Hypertension in newly diagnosed diabetic patients in Uganda
- Microalbuminuria and left ventricular dysfunction in type 2 diabetes
- SGLT-2 inhibitors in type 2 diabetes: protecting kidney and heart
- African roadmap: 25% hypertension control in Africa by 2025
RELIABLE EXPERT INFORMATION
The SAJDVD’s main focus is
providing new and relevant information for doctors,
nurses and allied professionals involved in caring
for the diabetes patient.
But as we are part of the larger Diabetes team, we would like to reach out to all patients with relevant information. So here it is!
But as we are part of the larger Diabetes team, we would like to reach out to all patients with relevant information. So here it is!
